Prescribing of paracetamol in patients with chronic renal failure A Drug Utilisation Study (Paracetamol doses in renal failure)

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/34517
• EU PAS number:
  EUPAS34516
• Study ID:
  34517
• Official title and acronym:
  Prescribing of paracetamol in patients with chronic renal failure A Drug Utilisation Study (Paracetamol doses in renal failure)
• DARWIN EU® study:
  No
• Study countries:
  Germany

  United Kingdom
• Study description:
  Paracetamol doses were studied in patients with and without renal failure.
• Study status:
  Finalised

Research institution and networks

Institutions

European Medicines Agency (EMA)

Contact details

Robert Flynn

Study contact

[e-mail]

Robert Flynn

Primary lead investigator

Study timelines

Date when funding contract was signed

Planned: 04/04/2019

Actual: 04/04/2019

Data collection

Planned: 03/05/2019

Actual: 03/05/2019

Date of final study report

Planned: 17/07/2019

Actual: 17/07/2019

Sources of funding

EMA

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable